Intranasal nerve growth factor administration improves neurological outcome after GBS meningitis
- 10 April 2020
- journal article
- case report
- Published by Springer Nature in Child's Nervous System
- Vol. 36 (9) , 2083-2088
Abstract
Nerve growth factor (NGF) is a neurotrophin that promotes neural recovery and plasticity after experimental brain injury, supporting neuronal growth, differentiation, and survival of brain cells. Only a few studies reported NGF administration in pediatric patients with impaired brain functions after traumatic injuries, ischemic or infectious diseases, such as meningitis. We described the beneficial therapeutic effects of human-recombinant nerve growth factor (hr-NGF) treatment in an infant with persistent unresponsive wakefulness syndrome (UWS), due to late-onset group B Streptococcus meningitis. The infant received five monthly cycles of intranasal hr-NGF (0.1 mg/kg, 3 times daily for 7 consecutive days) through a mucosal atomizer device (MAD). NGF administration improved functional [positron emission tomography/computed tomography (PET/CT), single-photon emission/computed tomography (SPECT/CT), and magnetic resonance imaging (MRI)] assessments, electrophysiological [Electroencephalogram (EEG)] studies, as well as main cognitive processes and clinical and neurological functions. After hr-NGF treatment, significant improvements in facial mimicry, attention, motor reactions, oral motility, and feeding capacity were observed. She also recovered some hypothalamic functions and her cough reflex was restored. No side effects were reported during and after the treatment. For the first time ever, hr-NGF has been successfully utilized in an infant with UWS and severe neurologic outcome due to a bacterial meningitis. Although further studies are needed for better understanding the neuroprotective role of this neurotrophin, intranasal hr-NGF administration appears to be a promising and save rescuing strategy treatment in infants with severe neurological impairment after brain damage.Keywords
This publication has 18 references indexed in Scilit:
- Virulence Factors of Meningitis-Causing Bacteria: Enabling Brain Entry across the Blood–Brain BarrierInternational Journal of Molecular Sciences, 2019
- Patterns of ischemic injury on brain images in neonatal group B Streptococcal meningitisKorean Journal of Pediatrics, 2018
- Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case reportBrain Injury, 2017
- Children and youth with non-traumatic brain injury: a population based perspectiveBMC Neurology, 2016
- Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trialBrain, 2016
- Nerve growth factor: basic studies and possible therapeutic applicationsGrowth Factors, 2013
- Long-term Outcomes of Group B Streptococcal MeningitisPediatrics, 2012
- Topical Nerve Growth Factor as a Visual Rescue Strategy in Pediatric Optic GliomasNeurorehabilitation and Neural Repair, 2011
- Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic–ischemic brain injuryNeurological Research, 2008
- The disability rating and Coma/Near-Coma scales in evaluating severe head injuryNeuropsychological Rehabilitation, 2005